Global Veterinary Vaccine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Veterinary Vaccine market size is predicted to grow from US$ 12120 million in 2025 to US$ 18400 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Factors influencing growth in demand for farm vaccines include:
• human population growth and increasing standards of living, particularly in many emerging markets;
• increasing demand for improved nutrition, particularly animal protein;
• natural resource constraints, such as scarcity of arable land, fresh water and increased competition for cultivated land, resulting in fewer resources that will be available to meet this increased demand for animal protein;
• increasing urbanization and increased focus on food safety and food security. Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally.
The primary companion animal species are dogs, cats and horses. Factors influencing growth in demand for companion animal vaccines include:
• economic development and related increases in disposable income, particularly in many emerging markets;
• increasing pet ownership
• companion animals living longer, increasing medical treatment of companion animals and advances in companion animal medicines and vaccines.
North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 30%.
Global key Veterinary Vaccine players cover Merck, Boehringer Ingelheim, Zoetis, Elanco, Ceva, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Virbac, etc. In terms of revenue, the global five largest companies occupied for a share nearly 75.64% in 2023.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Vaccine Industry Forecast” looks at past sales and reviews total world Veterinary Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Vaccine sales for 2025 through 2031. With Veterinary Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Veterinary Vaccine market?
What factors are driving Veterinary Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Vaccine market opportunities vary by end market size?
How does Veterinary Vaccine break out by Type, by Application?
The global Veterinary Vaccine market size is predicted to grow from US$ 12120 million in 2025 to US$ 18400 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Factors influencing growth in demand for farm vaccines include:
• human population growth and increasing standards of living, particularly in many emerging markets;
• increasing demand for improved nutrition, particularly animal protein;
• natural resource constraints, such as scarcity of arable land, fresh water and increased competition for cultivated land, resulting in fewer resources that will be available to meet this increased demand for animal protein;
• increasing urbanization and increased focus on food safety and food security. Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally.
The primary companion animal species are dogs, cats and horses. Factors influencing growth in demand for companion animal vaccines include:
• economic development and related increases in disposable income, particularly in many emerging markets;
• increasing pet ownership
• companion animals living longer, increasing medical treatment of companion animals and advances in companion animal medicines and vaccines.
North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 30%.
Global key Veterinary Vaccine players cover Merck, Boehringer Ingelheim, Zoetis, Elanco, Ceva, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Virbac, etc. In terms of revenue, the global five largest companies occupied for a share nearly 75.64% in 2023.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Vaccine Industry Forecast” looks at past sales and reviews total world Veterinary Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Vaccine sales for 2025 through 2031. With Veterinary Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Live Attenuated Vaccines
- Inactivated Vaccines
- Other
- Farm Animal
- Companion Animal
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- Jinyu Bio-Technology
- Medion
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- RVSRI
What is the 10-year outlook for the global Veterinary Vaccine market?
What factors are driving Veterinary Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Vaccine market opportunities vary by end market size?
How does Veterinary Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Veterinary Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Veterinary Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Veterinary Vaccine Segment by Type
2.2.1 Live Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.2.3 Other
2.3 Veterinary Vaccine Sales by Type
2.3.1 Global Veterinary Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Veterinary Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Veterinary Vaccine Sale Price by Type (2020-2025)
2.4 Veterinary Vaccine Segment by Application
2.4.1 Farm Animal
2.4.2 Companion Animal
2.5 Veterinary Vaccine Sales by Application
2.5.1 Global Veterinary Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Veterinary Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Veterinary Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Vaccine Breakdown Data by Company
3.1.1 Global Veterinary Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Veterinary Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Veterinary Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Veterinary Vaccine Revenue by Company (2020-2025)
3.2.2 Global Veterinary Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Veterinary Vaccine Sale Price by Company
3.4 Key Manufacturers Veterinary Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Vaccine Product Location Distribution
3.4.2 Players Veterinary Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Veterinary Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Veterinary Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Veterinary Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Veterinary Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Veterinary Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Vaccine Sales Growth
4.4 APAC Veterinary Vaccine Sales Growth
4.5 Europe Veterinary Vaccine Sales Growth
4.6 Middle East & Africa Veterinary Vaccine Sales Growth
5 AMERICAS
5.1 Americas Veterinary Vaccine Sales by Country
5.1.1 Americas Veterinary Vaccine Sales by Country (2020-2025)
5.1.2 Americas Veterinary Vaccine Revenue by Country (2020-2025)
5.2 Americas Veterinary Vaccine Sales by Type (2020-2025)
5.3 Americas Veterinary Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Vaccine Sales by Region
6.1.1 APAC Veterinary Vaccine Sales by Region (2020-2025)
6.1.2 APAC Veterinary Vaccine Revenue by Region (2020-2025)
6.2 APAC Veterinary Vaccine Sales by Type (2020-2025)
6.3 APAC Veterinary Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Vaccine by Country
7.1.1 Europe Veterinary Vaccine Sales by Country (2020-2025)
7.1.2 Europe Veterinary Vaccine Revenue by Country (2020-2025)
7.2 Europe Veterinary Vaccine Sales by Type (2020-2025)
7.3 Europe Veterinary Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Vaccine by Country
8.1.1 Middle East & Africa Veterinary Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Veterinary Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Veterinary Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Veterinary Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Vaccine
10.3 Manufacturing Process Analysis of Veterinary Vaccine
10.4 Industry Chain Structure of Veterinary Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Vaccine Distributors
11.3 Veterinary Vaccine Customer
12 WORLD FORECAST REVIEW FOR VETERINARY VACCINE BY GEOGRAPHIC REGION
12.1 Global Veterinary Vaccine Market Size Forecast by Region
12.1.1 Global Veterinary Vaccine Forecast by Region (2026-2031)
12.1.2 Global Veterinary Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Veterinary Vaccine Forecast by Type (2026-2031)
12.7 Global Veterinary Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Vaccine Product Portfolios and Specifications
13.1.3 Merck Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Vaccine Product Portfolios and Specifications
13.4.3 Ceva Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Vaccine Product Portfolios and Specifications
13.5.3 CAHIC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Vaccine Product Portfolios and Specifications
13.6.3 HVRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Ringpu Biology
13.7.1 Ringpu Biology Company Information
13.7.2 Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
13.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ringpu Biology Main Business Overview
13.7.5 Ringpu Biology Latest Developments
13.8 Yebio
13.8.1 Yebio Company Information
13.8.2 Yebio Veterinary Vaccine Product Portfolios and Specifications
13.8.3 Yebio Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Yebio Main Business Overview
13.8.5 Yebio Latest Developments
13.9 DHN
13.9.1 DHN Company Information
13.9.2 DHN Veterinary Vaccine Product Portfolios and Specifications
13.9.3 DHN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 DHN Main Business Overview
13.9.5 DHN Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Veterinary Vaccine Product Portfolios and Specifications
13.10.3 WINSUN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Elanco
13.11.1 Elanco Company Information
13.11.2 Elanco Veterinary Vaccine Product Portfolios and Specifications
13.11.3 Elanco Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Elanco Main Business Overview
13.11.5 Elanco Latest Developments
13.12 Virbac
13.12.1 Virbac Company Information
13.12.2 Virbac Veterinary Vaccine Product Portfolios and Specifications
13.12.3 Virbac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Virbac Main Business Overview
13.12.5 Virbac Latest Developments
13.13 Jinyu Bio-Technology
13.13.1 Jinyu Bio-Technology Company Information
13.13.2 Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
13.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Jinyu Bio-Technology Main Business Overview
13.13.5 Jinyu Bio-Technology Latest Developments
13.14 Medion
13.14.1 Medion Company Information
13.14.2 Medion Veterinary Vaccine Product Portfolios and Specifications
13.14.3 Medion Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Medion Main Business Overview
13.14.5 Medion Latest Developments
13.15 CAVAC
13.15.1 CAVAC Company Information
13.15.2 CAVAC Veterinary Vaccine Product Portfolios and Specifications
13.15.3 CAVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 CAVAC Main Business Overview
13.15.5 CAVAC Latest Developments
13.16 Kyoto Biken Laboratories
13.16.1 Kyoto Biken Laboratories Company Information
13.16.2 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
13.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Kyoto Biken Laboratories Main Business Overview
13.16.5 Kyoto Biken Laboratories Latest Developments
13.17 FATRO
13.17.1 FATRO Company Information
13.17.2 FATRO Veterinary Vaccine Product Portfolios and Specifications
13.17.3 FATRO Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 FATRO Main Business Overview
13.17.5 FATRO Latest Developments
13.18 Vaksindo
13.18.1 Vaksindo Company Information
13.18.2 Vaksindo Veterinary Vaccine Product Portfolios and Specifications
13.18.3 Vaksindo Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Vaksindo Main Business Overview
13.18.5 Vaksindo Latest Developments
13.19 Bio-Labs
13.19.1 Bio-Labs Company Information
13.19.2 Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
13.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Bio-Labs Main Business Overview
13.19.5 Bio-Labs Latest Developments
13.20 Avimex Animal Health
13.20.1 Avimex Animal Health Company Information
13.20.2 Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
13.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Avimex Animal Health Main Business Overview
13.20.5 Avimex Animal Health Latest Developments
13.21 MEVAC
13.21.1 MEVAC Company Information
13.21.2 MEVAC Veterinary Vaccine Product Portfolios and Specifications
13.21.3 MEVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 MEVAC Main Business Overview
13.21.5 MEVAC Latest Developments
13.22 Biovac
13.22.1 Biovac Company Information
13.22.2 Biovac Veterinary Vaccine Product Portfolios and Specifications
13.22.3 Biovac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Biovac Main Business Overview
13.22.5 Biovac Latest Developments
13.23 Atafen
13.23.1 Atafen Company Information
13.23.2 Atafen Veterinary Vaccine Product Portfolios and Specifications
13.23.3 Atafen Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Atafen Main Business Overview
13.23.5 Atafen Latest Developments
13.24 Dyntec
13.24.1 Dyntec Company Information
13.24.2 Dyntec Veterinary Vaccine Product Portfolios and Specifications
13.24.3 Dyntec Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Dyntec Main Business Overview
13.24.5 Dyntec Latest Developments
13.25 RVSRI
13.25.1 RVSRI Company Information
13.25.2 RVSRI Veterinary Vaccine Product Portfolios and Specifications
13.25.3 RVSRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 RVSRI Main Business Overview
13.25.5 RVSRI Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Veterinary Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Veterinary Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Major Players of Other
Table 6. Global Veterinary Vaccine Sales byType (2020-2025) & (M Doses)
Table 7. Global Veterinary Vaccine Sales Market Share byType (2020-2025)
Table 8. Global Veterinary Vaccine Revenue byType (2020-2025) & ($ million)
Table 9. Global Veterinary Vaccine Revenue Market Share byType (2020-2025)
Table 10. Global Veterinary Vaccine Sale Price byType (2020-2025) & (USD/K Doses)
Table 11. Global Veterinary Vaccine Sale by Application (2020-2025) & (M Doses)
Table 12. Global Veterinary Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Veterinary Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Veterinary Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Veterinary Vaccine Sale Price by Application (2020-2025) & (USD/K Doses)
Table 16. Global Veterinary Vaccine Sales by Company (2020-2025) & (M Doses)
Table 17. Global Veterinary Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Veterinary Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Veterinary Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Veterinary Vaccine Sale Price by Company (2020-2025) & (USD/K Doses)
Table 21. Key Manufacturers Veterinary Vaccine Producing Area Distribution and Sales Area
Table 22. Players Veterinary Vaccine Products Offered
Table 23. Veterinary Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Veterinary Vaccine Sales by Geographic Region (2020-2025) & (M Doses)
Table 27. Global Veterinary Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Veterinary Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Veterinary Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Veterinary Vaccine Sales by Country/Region (2020-2025) & (M Doses)
Table 31. Global Veterinary Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Veterinary Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Veterinary Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 35. Americas Veterinary Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Veterinary Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Veterinary Vaccine Sales byType (2020-2025) & (M Doses)
Table 38. Americas Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 39. APAC Veterinary Vaccine Sales by Region (2020-2025) & (M Doses)
Table 40. APAC Veterinary Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Veterinary Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Veterinary Vaccine Sales byType (2020-2025) & (M Doses)
Table 43. APAC Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 44. Europe Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 45. Europe Veterinary Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Veterinary Vaccine Sales byType (2020-2025) & (M Doses)
Table 47. Europe Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 48. Middle East & Africa Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 49. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Veterinary Vaccine Sales byType (2020-2025) & (M Doses)
Table 51. Middle East & Africa Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 52. Key Market Drivers & Growth Opportunities of Veterinary Vaccine
Table 53. Key Market Challenges & Risks of Veterinary Vaccine
Table 54. Key IndustryTrends of Veterinary Vaccine
Table 55. Veterinary Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Veterinary Vaccine Distributors List
Table 58. Veterinary Vaccine Customer List
Table 59. Global Veterinary Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 60. Global Veterinary Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Veterinary Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 62. Americas Veterinary Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Veterinary Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 64. APAC Veterinary Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Veterinary Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 66. Europe Veterinary Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Veterinary Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 68. Middle East & Africa Veterinary Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Veterinary Vaccine SalesForecast byType (2026-2031) & (M Doses)
Table 70. Global Veterinary Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Veterinary Vaccine SalesForecast by Application (2026-2031) & (M Doses)
Table 72. Global Veterinary Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Veterinary Vaccine Product Portfolios and Specifications
Table 75. Merck Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Zoetis Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Veterinary Vaccine Product Portfolios and Specifications
Table 80. Zoetis Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Boehringer Ingelheim Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
Table 85. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 86. Boehringer Ingelheim Main Business
Table 87. Boehringer Ingelheim Latest Developments
Table 88. Ceva Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Ceva Veterinary Vaccine Product Portfolios and Specifications
Table 90. Ceva Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 91. Ceva Main Business
Table 92. Ceva Latest Developments
Table 93. CAHIC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. CAHIC Veterinary Vaccine Product Portfolios and Specifications
Table 95. CAHIC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 96. CAHIC Main Business
Table 97. CAHIC Latest Developments
Table 98. HVRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. HVRI Veterinary Vaccine Product Portfolios and Specifications
Table 100. HVRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 101. HVRI Main Business
Table 102. HVRI Latest Developments
Table 103. Ringpu Biology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
Table 105. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 106. Ringpu Biology Main Business
Table 107. Ringpu Biology Latest Developments
Table 108. Yebio Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Yebio Veterinary Vaccine Product Portfolios and Specifications
Table 110. Yebio Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 111. Yebio Main Business
Table 112. Yebio Latest Developments
Table 113. DHN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. DHN Veterinary Vaccine Product Portfolios and Specifications
Table 115. DHN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 116. DHN Main Business
Table 117. DHN Latest Developments
Table 118. WINSUN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. WINSUN Veterinary Vaccine Product Portfolios and Specifications
Table 120. WINSUN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 121. WINSUN Main Business
Table 122. WINSUN Latest Developments
Table 123. Elanco Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Elanco Veterinary Vaccine Product Portfolios and Specifications
Table 125. Elanco Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 126. Elanco Main Business
Table 127. Elanco Latest Developments
Table 128. Virbac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Virbac Veterinary Vaccine Product Portfolios and Specifications
Table 130. Virbac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 131. Virbac Main Business
Table 132. Virbac Latest Developments
Table 133. Jinyu Bio-Technology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
Table 135. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 136. Jinyu Bio-Technology Main Business
Table 137. Jinyu Bio-Technology Latest Developments
Table 138. Medion Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Medion Veterinary Vaccine Product Portfolios and Specifications
Table 140. Medion Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 141. Medion Main Business
Table 142. Medion Latest Developments
Table 143. CAVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. CAVAC Veterinary Vaccine Product Portfolios and Specifications
Table 145. CAVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 146. CAVAC Main Business
Table 147. CAVAC Latest Developments
Table 148. Kyoto Biken Laboratories Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
Table 150. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 151. Kyoto Biken Laboratories Main Business
Table 152. Kyoto Biken Laboratories Latest Developments
Table 153.FATRO Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154.FATRO Veterinary Vaccine Product Portfolios and Specifications
Table 155.FATRO Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 156.FATRO Main Business
Table 157.FATRO Latest Developments
Table 158. Vaksindo Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Vaksindo Veterinary Vaccine Product Portfolios and Specifications
Table 160. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 161. Vaksindo Main Business
Table 162. Vaksindo Latest Developments
Table 163. Bio-Labs Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 164. Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
Table 165. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 166. Bio-Labs Main Business
Table 167. Bio-Labs Latest Developments
Table 168. Avimex Animal Health Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 169. Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
Table 170. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 171. Avimex Animal Health Main Business
Table 172. Avimex Animal Health Latest Developments
Table 173. MEVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 174. MEVAC Veterinary Vaccine Product Portfolios and Specifications
Table 175. MEVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 176. MEVAC Main Business
Table 177. MEVAC Latest Developments
Table 178. Biovac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 179. Biovac Veterinary Vaccine Product Portfolios and Specifications
Table 180. Biovac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 181. Biovac Main Business
Table 182. Biovac Latest Developments
Table 183. Atafen Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 184. Atafen Veterinary Vaccine Product Portfolios and Specifications
Table 185. Atafen Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 186. Atafen Main Business
Table 187. Atafen Latest Developments
Table 188. Dyntec Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 189. Dyntec Veterinary Vaccine Product Portfolios and Specifications
Table 190. Dyntec Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 191. Dyntec Main Business
Table 192. Dyntec Latest Developments
Table 193. RVSRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 194. RVSRI Veterinary Vaccine Product Portfolios and Specifications
Table 195. RVSRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 196. RVSRI Main Business
Table 197. RVSRI Latest Developments
LIST OFFIGURES
Figure 1. Picture of Veterinary Vaccine
Figure 2. Veterinary Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Vaccine Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Veterinary Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Veterinary Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Veterinary Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Veterinary Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Live Attenuated Vaccines
Figure 12. Product Picture of Inactivated Vaccines
Figure 13. Product Picture of Other
Figure 14. Global Veterinary Vaccine Sales Market Share byType in 2025
Figure 15. Global Veterinary Vaccine Revenue Market Share byType (2020-2025)
Figure 16. Veterinary Vaccine Consumed inFarm Animal
Figure 17. Global Veterinary Vaccine Market:Farm Animal (2020-2025) & (M Doses)
Figure 18. Veterinary Vaccine Consumed in Companion Animal
Figure 19. Global Veterinary Vaccine Market: Companion Animal (2020-2025) & (M Doses)
Figure 20. Global Veterinary Vaccine Sale Market Share by Application (2024)
Figure 21. Global Veterinary Vaccine Revenue Market Share by Application in 2025
Figure 22. Veterinary Vaccine Sales by Company in 2025 (M Doses)
Figure 23. Global Veterinary Vaccine Sales Market Share by Company in 2025
Figure 24. Veterinary Vaccine Revenue by Company in 2025 ($ millions)
Figure 25. Global Veterinary Vaccine Revenue Market Share by Company in 2025
Figure 26. Global Veterinary Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Veterinary Vaccine Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Veterinary Vaccine Sales 2020-2025 (M Doses)
Figure 29. Americas Veterinary Vaccine Revenue 2020-2025 ($ millions)
Figure 30. APAC Veterinary Vaccine Sales 2020-2025 (M Doses)
Figure 31. APAC Veterinary Vaccine Revenue 2020-2025 ($ millions)
Figure 32. Europe Veterinary Vaccine Sales 2020-2025 (M Doses)
Figure 33. Europe Veterinary Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Veterinary Vaccine Sales 2020-2025 (M Doses)
Figure 35. Middle East & Africa Veterinary Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Americas Veterinary Vaccine Sales Market Share by Country in 2025
Figure 37. Americas Veterinary Vaccine Revenue Market Share by Country (2020-2025)
Figure 38. Americas Veterinary Vaccine Sales Market Share byType (2020-2025)
Figure 39. Americas Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 40. United States Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Veterinary Vaccine Sales Market Share by Region in 2025
Figure 45. APAC Veterinary Vaccine Revenue Market Share by Region (2020-2025)
Figure 46. APAC Veterinary Vaccine Sales Market Share byType (2020-2025)
Figure 47. APAC Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 48. China Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. India Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwan Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Veterinary Vaccine Sales Market Share by Country in 2025
Figure 56. Europe Veterinary Vaccine Revenue Market Share by Country (2020-2025)
Figure 57. Europe Veterinary Vaccine Sales Market Share byType (2020-2025)
Figure 58. Europe Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 59. Germany Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60.France Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Veterinary Vaccine Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Veterinary Vaccine Sales Market Share byType (2020-2025)
Figure 66. Middle East & Africa Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 67. Egypt Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70.Turkey Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Veterinary Vaccine in 2025
Figure 73. Manufacturing Process Analysis of Veterinary Vaccine
Figure 74. Industry Chain Structure of Veterinary Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Veterinary Vaccine Sales MarketForecast by Region (2026-2031)
Figure 77. Global Veterinary Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 78. Global Veterinary Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 79. Global Veterinary Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 80. Global Veterinary Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 81. Global Veterinary Vaccine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Veterinary Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Veterinary Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Veterinary Vaccine Segment by Type
2.2.1 Live Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.2.3 Other
2.3 Veterinary Vaccine Sales by Type
2.3.1 Global Veterinary Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Veterinary Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Veterinary Vaccine Sale Price by Type (2020-2025)
2.4 Veterinary Vaccine Segment by Application
2.4.1 Farm Animal
2.4.2 Companion Animal
2.5 Veterinary Vaccine Sales by Application
2.5.1 Global Veterinary Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Veterinary Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Veterinary Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Vaccine Breakdown Data by Company
3.1.1 Global Veterinary Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Veterinary Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Veterinary Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Veterinary Vaccine Revenue by Company (2020-2025)
3.2.2 Global Veterinary Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Veterinary Vaccine Sale Price by Company
3.4 Key Manufacturers Veterinary Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Vaccine Product Location Distribution
3.4.2 Players Veterinary Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Veterinary Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Veterinary Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Veterinary Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Veterinary Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Veterinary Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Vaccine Sales Growth
4.4 APAC Veterinary Vaccine Sales Growth
4.5 Europe Veterinary Vaccine Sales Growth
4.6 Middle East & Africa Veterinary Vaccine Sales Growth
5 AMERICAS
5.1 Americas Veterinary Vaccine Sales by Country
5.1.1 Americas Veterinary Vaccine Sales by Country (2020-2025)
5.1.2 Americas Veterinary Vaccine Revenue by Country (2020-2025)
5.2 Americas Veterinary Vaccine Sales by Type (2020-2025)
5.3 Americas Veterinary Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Vaccine Sales by Region
6.1.1 APAC Veterinary Vaccine Sales by Region (2020-2025)
6.1.2 APAC Veterinary Vaccine Revenue by Region (2020-2025)
6.2 APAC Veterinary Vaccine Sales by Type (2020-2025)
6.3 APAC Veterinary Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Vaccine by Country
7.1.1 Europe Veterinary Vaccine Sales by Country (2020-2025)
7.1.2 Europe Veterinary Vaccine Revenue by Country (2020-2025)
7.2 Europe Veterinary Vaccine Sales by Type (2020-2025)
7.3 Europe Veterinary Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Vaccine by Country
8.1.1 Middle East & Africa Veterinary Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Veterinary Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Veterinary Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Veterinary Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Vaccine
10.3 Manufacturing Process Analysis of Veterinary Vaccine
10.4 Industry Chain Structure of Veterinary Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Vaccine Distributors
11.3 Veterinary Vaccine Customer
12 WORLD FORECAST REVIEW FOR VETERINARY VACCINE BY GEOGRAPHIC REGION
12.1 Global Veterinary Vaccine Market Size Forecast by Region
12.1.1 Global Veterinary Vaccine Forecast by Region (2026-2031)
12.1.2 Global Veterinary Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Veterinary Vaccine Forecast by Type (2026-2031)
12.7 Global Veterinary Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Vaccine Product Portfolios and Specifications
13.1.3 Merck Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Vaccine Product Portfolios and Specifications
13.4.3 Ceva Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Vaccine Product Portfolios and Specifications
13.5.3 CAHIC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Vaccine Product Portfolios and Specifications
13.6.3 HVRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Ringpu Biology
13.7.1 Ringpu Biology Company Information
13.7.2 Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
13.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ringpu Biology Main Business Overview
13.7.5 Ringpu Biology Latest Developments
13.8 Yebio
13.8.1 Yebio Company Information
13.8.2 Yebio Veterinary Vaccine Product Portfolios and Specifications
13.8.3 Yebio Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Yebio Main Business Overview
13.8.5 Yebio Latest Developments
13.9 DHN
13.9.1 DHN Company Information
13.9.2 DHN Veterinary Vaccine Product Portfolios and Specifications
13.9.3 DHN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 DHN Main Business Overview
13.9.5 DHN Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Veterinary Vaccine Product Portfolios and Specifications
13.10.3 WINSUN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Elanco
13.11.1 Elanco Company Information
13.11.2 Elanco Veterinary Vaccine Product Portfolios and Specifications
13.11.3 Elanco Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Elanco Main Business Overview
13.11.5 Elanco Latest Developments
13.12 Virbac
13.12.1 Virbac Company Information
13.12.2 Virbac Veterinary Vaccine Product Portfolios and Specifications
13.12.3 Virbac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Virbac Main Business Overview
13.12.5 Virbac Latest Developments
13.13 Jinyu Bio-Technology
13.13.1 Jinyu Bio-Technology Company Information
13.13.2 Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
13.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Jinyu Bio-Technology Main Business Overview
13.13.5 Jinyu Bio-Technology Latest Developments
13.14 Medion
13.14.1 Medion Company Information
13.14.2 Medion Veterinary Vaccine Product Portfolios and Specifications
13.14.3 Medion Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Medion Main Business Overview
13.14.5 Medion Latest Developments
13.15 CAVAC
13.15.1 CAVAC Company Information
13.15.2 CAVAC Veterinary Vaccine Product Portfolios and Specifications
13.15.3 CAVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 CAVAC Main Business Overview
13.15.5 CAVAC Latest Developments
13.16 Kyoto Biken Laboratories
13.16.1 Kyoto Biken Laboratories Company Information
13.16.2 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
13.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Kyoto Biken Laboratories Main Business Overview
13.16.5 Kyoto Biken Laboratories Latest Developments
13.17 FATRO
13.17.1 FATRO Company Information
13.17.2 FATRO Veterinary Vaccine Product Portfolios and Specifications
13.17.3 FATRO Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 FATRO Main Business Overview
13.17.5 FATRO Latest Developments
13.18 Vaksindo
13.18.1 Vaksindo Company Information
13.18.2 Vaksindo Veterinary Vaccine Product Portfolios and Specifications
13.18.3 Vaksindo Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Vaksindo Main Business Overview
13.18.5 Vaksindo Latest Developments
13.19 Bio-Labs
13.19.1 Bio-Labs Company Information
13.19.2 Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
13.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Bio-Labs Main Business Overview
13.19.5 Bio-Labs Latest Developments
13.20 Avimex Animal Health
13.20.1 Avimex Animal Health Company Information
13.20.2 Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
13.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Avimex Animal Health Main Business Overview
13.20.5 Avimex Animal Health Latest Developments
13.21 MEVAC
13.21.1 MEVAC Company Information
13.21.2 MEVAC Veterinary Vaccine Product Portfolios and Specifications
13.21.3 MEVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 MEVAC Main Business Overview
13.21.5 MEVAC Latest Developments
13.22 Biovac
13.22.1 Biovac Company Information
13.22.2 Biovac Veterinary Vaccine Product Portfolios and Specifications
13.22.3 Biovac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Biovac Main Business Overview
13.22.5 Biovac Latest Developments
13.23 Atafen
13.23.1 Atafen Company Information
13.23.2 Atafen Veterinary Vaccine Product Portfolios and Specifications
13.23.3 Atafen Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Atafen Main Business Overview
13.23.5 Atafen Latest Developments
13.24 Dyntec
13.24.1 Dyntec Company Information
13.24.2 Dyntec Veterinary Vaccine Product Portfolios and Specifications
13.24.3 Dyntec Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Dyntec Main Business Overview
13.24.5 Dyntec Latest Developments
13.25 RVSRI
13.25.1 RVSRI Company Information
13.25.2 RVSRI Veterinary Vaccine Product Portfolios and Specifications
13.25.3 RVSRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 RVSRI Main Business Overview
13.25.5 RVSRI Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Veterinary Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Veterinary Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Major Players of Other
Table 6. Global Veterinary Vaccine Sales byType (2020-2025) & (M Doses)
Table 7. Global Veterinary Vaccine Sales Market Share byType (2020-2025)
Table 8. Global Veterinary Vaccine Revenue byType (2020-2025) & ($ million)
Table 9. Global Veterinary Vaccine Revenue Market Share byType (2020-2025)
Table 10. Global Veterinary Vaccine Sale Price byType (2020-2025) & (USD/K Doses)
Table 11. Global Veterinary Vaccine Sale by Application (2020-2025) & (M Doses)
Table 12. Global Veterinary Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Veterinary Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Veterinary Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Veterinary Vaccine Sale Price by Application (2020-2025) & (USD/K Doses)
Table 16. Global Veterinary Vaccine Sales by Company (2020-2025) & (M Doses)
Table 17. Global Veterinary Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Veterinary Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Veterinary Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Veterinary Vaccine Sale Price by Company (2020-2025) & (USD/K Doses)
Table 21. Key Manufacturers Veterinary Vaccine Producing Area Distribution and Sales Area
Table 22. Players Veterinary Vaccine Products Offered
Table 23. Veterinary Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Veterinary Vaccine Sales by Geographic Region (2020-2025) & (M Doses)
Table 27. Global Veterinary Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Veterinary Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Veterinary Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Veterinary Vaccine Sales by Country/Region (2020-2025) & (M Doses)
Table 31. Global Veterinary Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Veterinary Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Veterinary Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 35. Americas Veterinary Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Veterinary Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Veterinary Vaccine Sales byType (2020-2025) & (M Doses)
Table 38. Americas Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 39. APAC Veterinary Vaccine Sales by Region (2020-2025) & (M Doses)
Table 40. APAC Veterinary Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Veterinary Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Veterinary Vaccine Sales byType (2020-2025) & (M Doses)
Table 43. APAC Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 44. Europe Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 45. Europe Veterinary Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Veterinary Vaccine Sales byType (2020-2025) & (M Doses)
Table 47. Europe Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 48. Middle East & Africa Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 49. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Veterinary Vaccine Sales byType (2020-2025) & (M Doses)
Table 51. Middle East & Africa Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 52. Key Market Drivers & Growth Opportunities of Veterinary Vaccine
Table 53. Key Market Challenges & Risks of Veterinary Vaccine
Table 54. Key IndustryTrends of Veterinary Vaccine
Table 55. Veterinary Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Veterinary Vaccine Distributors List
Table 58. Veterinary Vaccine Customer List
Table 59. Global Veterinary Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 60. Global Veterinary Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Veterinary Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 62. Americas Veterinary Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Veterinary Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 64. APAC Veterinary Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Veterinary Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 66. Europe Veterinary Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Veterinary Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 68. Middle East & Africa Veterinary Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Veterinary Vaccine SalesForecast byType (2026-2031) & (M Doses)
Table 70. Global Veterinary Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Veterinary Vaccine SalesForecast by Application (2026-2031) & (M Doses)
Table 72. Global Veterinary Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Veterinary Vaccine Product Portfolios and Specifications
Table 75. Merck Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Zoetis Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Veterinary Vaccine Product Portfolios and Specifications
Table 80. Zoetis Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Boehringer Ingelheim Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
Table 85. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 86. Boehringer Ingelheim Main Business
Table 87. Boehringer Ingelheim Latest Developments
Table 88. Ceva Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Ceva Veterinary Vaccine Product Portfolios and Specifications
Table 90. Ceva Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 91. Ceva Main Business
Table 92. Ceva Latest Developments
Table 93. CAHIC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. CAHIC Veterinary Vaccine Product Portfolios and Specifications
Table 95. CAHIC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 96. CAHIC Main Business
Table 97. CAHIC Latest Developments
Table 98. HVRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. HVRI Veterinary Vaccine Product Portfolios and Specifications
Table 100. HVRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 101. HVRI Main Business
Table 102. HVRI Latest Developments
Table 103. Ringpu Biology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
Table 105. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 106. Ringpu Biology Main Business
Table 107. Ringpu Biology Latest Developments
Table 108. Yebio Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Yebio Veterinary Vaccine Product Portfolios and Specifications
Table 110. Yebio Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 111. Yebio Main Business
Table 112. Yebio Latest Developments
Table 113. DHN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. DHN Veterinary Vaccine Product Portfolios and Specifications
Table 115. DHN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 116. DHN Main Business
Table 117. DHN Latest Developments
Table 118. WINSUN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. WINSUN Veterinary Vaccine Product Portfolios and Specifications
Table 120. WINSUN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 121. WINSUN Main Business
Table 122. WINSUN Latest Developments
Table 123. Elanco Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Elanco Veterinary Vaccine Product Portfolios and Specifications
Table 125. Elanco Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 126. Elanco Main Business
Table 127. Elanco Latest Developments
Table 128. Virbac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Virbac Veterinary Vaccine Product Portfolios and Specifications
Table 130. Virbac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 131. Virbac Main Business
Table 132. Virbac Latest Developments
Table 133. Jinyu Bio-Technology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
Table 135. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 136. Jinyu Bio-Technology Main Business
Table 137. Jinyu Bio-Technology Latest Developments
Table 138. Medion Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Medion Veterinary Vaccine Product Portfolios and Specifications
Table 140. Medion Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 141. Medion Main Business
Table 142. Medion Latest Developments
Table 143. CAVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. CAVAC Veterinary Vaccine Product Portfolios and Specifications
Table 145. CAVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 146. CAVAC Main Business
Table 147. CAVAC Latest Developments
Table 148. Kyoto Biken Laboratories Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
Table 150. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 151. Kyoto Biken Laboratories Main Business
Table 152. Kyoto Biken Laboratories Latest Developments
Table 153.FATRO Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154.FATRO Veterinary Vaccine Product Portfolios and Specifications
Table 155.FATRO Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 156.FATRO Main Business
Table 157.FATRO Latest Developments
Table 158. Vaksindo Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Vaksindo Veterinary Vaccine Product Portfolios and Specifications
Table 160. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 161. Vaksindo Main Business
Table 162. Vaksindo Latest Developments
Table 163. Bio-Labs Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 164. Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
Table 165. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 166. Bio-Labs Main Business
Table 167. Bio-Labs Latest Developments
Table 168. Avimex Animal Health Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 169. Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
Table 170. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 171. Avimex Animal Health Main Business
Table 172. Avimex Animal Health Latest Developments
Table 173. MEVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 174. MEVAC Veterinary Vaccine Product Portfolios and Specifications
Table 175. MEVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 176. MEVAC Main Business
Table 177. MEVAC Latest Developments
Table 178. Biovac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 179. Biovac Veterinary Vaccine Product Portfolios and Specifications
Table 180. Biovac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 181. Biovac Main Business
Table 182. Biovac Latest Developments
Table 183. Atafen Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 184. Atafen Veterinary Vaccine Product Portfolios and Specifications
Table 185. Atafen Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 186. Atafen Main Business
Table 187. Atafen Latest Developments
Table 188. Dyntec Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 189. Dyntec Veterinary Vaccine Product Portfolios and Specifications
Table 190. Dyntec Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 191. Dyntec Main Business
Table 192. Dyntec Latest Developments
Table 193. RVSRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 194. RVSRI Veterinary Vaccine Product Portfolios and Specifications
Table 195. RVSRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 196. RVSRI Main Business
Table 197. RVSRI Latest Developments
LIST OFFIGURES
Figure 1. Picture of Veterinary Vaccine
Figure 2. Veterinary Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Vaccine Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Veterinary Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Veterinary Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Veterinary Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Veterinary Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Live Attenuated Vaccines
Figure 12. Product Picture of Inactivated Vaccines
Figure 13. Product Picture of Other
Figure 14. Global Veterinary Vaccine Sales Market Share byType in 2025
Figure 15. Global Veterinary Vaccine Revenue Market Share byType (2020-2025)
Figure 16. Veterinary Vaccine Consumed inFarm Animal
Figure 17. Global Veterinary Vaccine Market:Farm Animal (2020-2025) & (M Doses)
Figure 18. Veterinary Vaccine Consumed in Companion Animal
Figure 19. Global Veterinary Vaccine Market: Companion Animal (2020-2025) & (M Doses)
Figure 20. Global Veterinary Vaccine Sale Market Share by Application (2024)
Figure 21. Global Veterinary Vaccine Revenue Market Share by Application in 2025
Figure 22. Veterinary Vaccine Sales by Company in 2025 (M Doses)
Figure 23. Global Veterinary Vaccine Sales Market Share by Company in 2025
Figure 24. Veterinary Vaccine Revenue by Company in 2025 ($ millions)
Figure 25. Global Veterinary Vaccine Revenue Market Share by Company in 2025
Figure 26. Global Veterinary Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Veterinary Vaccine Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Veterinary Vaccine Sales 2020-2025 (M Doses)
Figure 29. Americas Veterinary Vaccine Revenue 2020-2025 ($ millions)
Figure 30. APAC Veterinary Vaccine Sales 2020-2025 (M Doses)
Figure 31. APAC Veterinary Vaccine Revenue 2020-2025 ($ millions)
Figure 32. Europe Veterinary Vaccine Sales 2020-2025 (M Doses)
Figure 33. Europe Veterinary Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Veterinary Vaccine Sales 2020-2025 (M Doses)
Figure 35. Middle East & Africa Veterinary Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Americas Veterinary Vaccine Sales Market Share by Country in 2025
Figure 37. Americas Veterinary Vaccine Revenue Market Share by Country (2020-2025)
Figure 38. Americas Veterinary Vaccine Sales Market Share byType (2020-2025)
Figure 39. Americas Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 40. United States Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Veterinary Vaccine Sales Market Share by Region in 2025
Figure 45. APAC Veterinary Vaccine Revenue Market Share by Region (2020-2025)
Figure 46. APAC Veterinary Vaccine Sales Market Share byType (2020-2025)
Figure 47. APAC Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 48. China Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. India Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwan Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Veterinary Vaccine Sales Market Share by Country in 2025
Figure 56. Europe Veterinary Vaccine Revenue Market Share by Country (2020-2025)
Figure 57. Europe Veterinary Vaccine Sales Market Share byType (2020-2025)
Figure 58. Europe Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 59. Germany Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60.France Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Veterinary Vaccine Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Veterinary Vaccine Sales Market Share byType (2020-2025)
Figure 66. Middle East & Africa Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 67. Egypt Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70.Turkey Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Veterinary Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Veterinary Vaccine in 2025
Figure 73. Manufacturing Process Analysis of Veterinary Vaccine
Figure 74. Industry Chain Structure of Veterinary Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Veterinary Vaccine Sales MarketForecast by Region (2026-2031)
Figure 77. Global Veterinary Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 78. Global Veterinary Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 79. Global Veterinary Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 80. Global Veterinary Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 81. Global Veterinary Vaccine Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Veterinary Vaccine Adjuvants Market Growth 2025-2031
US$ 3,660.00
March 2025
86 pages
